相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Catheterization of Pulmonary and Carotid Arteries for Concurrent Measurement of Mean Pulmonary and Systemic Arterial Pressure in Rat Models of Pulmonary Arterial Hypertension
Tanoy Sarkar et al.
BIO-PROTOCOL (2023)
Metformin capped Cu2(OH)3Cl nanosheets for chemodynamic wound disinfection
Xueyu Wang et al.
NANO RESEARCH (2023)
Passively-targeted mitochondrial tungsten-based nanodots for efficient acute kidney injury treatment
Qiong Huang et al.
BIOACTIVE MATERIALS (2023)
Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney
Qiaohui Chen et al.
BIOACTIVE MATERIALS (2023)
PEG-Like Brush Polymer Conjugate of RNA Aptamer That Shows Reversible Anticoagulant Activity and Minimal Immune Response
Imran Ozer et al.
ADVANCED MATERIALS (2022)
HIV-associated Pulmonary Arterial Hypertension: A Report from the Pulmonary Hypertension Association Registry
Nicholas A. Kolaitis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Click and Bioorthogonal Chemistry: The Future of Active Targeting of Nanoparticles for Nanomedicines?
Ludivine Taiariol et al.
CHEMICAL REVIEWS (2022)
Targeted treprostinil delivery inhibits pulmonary arterial remodeling
Aijun Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
The physiological basis of pulmonary arterial hypertension
Robert Naeije et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension
Takeshi Ogo et al.
EUROPEAN RESPIRATORY JOURNAL (2022)
Targeted delivery of baicalein-p53 complex to smooth muscle cells reverses pulmonary hypertension
Chao Teng et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Rheumatoid arthritis microenvironment insights into treatment effect of nanomaterials
Yan Zhu et al.
NANO TODAY (2022)
Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy
Jia Huang et al.
FRONTIERS IN PHARMACOLOGY (2022)
Polymer-Tethered Nanoparticles: From Surface Engineering to Directional Self-Assembly Published as part of the Accounts of Chemical Research special issue Self-Assembled Nanomaterials
Ning-Ning Zhang et al.
ACCOUNTS OF CHEMICAL RESEARCH (2022)
Mechanisms of selective monocyte targeting by liposomes functionalized with a cationic, arginine-rich lipopeptide
Rasmus Munter et al.
ACTA BIOMATERIALIA (2022)
Inhaled Iloprost Improves Right Ventricular Load-Independent Contractility in Pulmonary Hypertension
Khodr Tello et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)
Heteroplasmy of Wild-Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty
Ana Victoria Lechuga-Vieco et al.
CIRCULATION (2022)
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure
Olivier Boucherat et al.
CIRCULATION RESEARCH (2022)
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo-controlled multicentre trial
Trond J. Cooper et al.
EUROPEAN JOURNAL OF HEART FAILURE (2022)
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure
Filippos Triposkiadis et al.
HEART FAILURE REVIEWS (2022)
Diagnosis and Treatment of Pulmonary Arterial Hypertension A Review
Nicole F. Ruopp et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
Nanomedicine: controlling nanoparticle clearance for translational success
Geyunjian Harry Zhu et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
SIRT 1 Activator Loaded Inhaled Antiangiogenic Liposomal Formulation Development for Pulmonary Hypertension
Sagar Dhoble et al.
AAPS PHARMSCITECH (2022)
Piezotronic Effect-Augmented Cu2-x-O-BaTiO3 Sonosensitizers for Multifunctional Cancer Dynamic Therapy
Yunchao Zhao et al.
ACS NANO (2022)
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications
Kazunori Omote et al.
EUROPEAN HEART JOURNAL (2022)
Nanomedicine Strategies for Heating Cold Ovarian Cancer (OC): Next Evolution in Immunotherapy of OC
Yuqi Yang et al.
ADVANCED SCIENCE (2022)
State-of-the-art advancements in Liver-on-a-chip (LOC): Integrated biosensors for LOC
Min Liu et al.
BIOSENSORS & BIOELECTRONICS (2022)
Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy
Seyedeh Alia Moosavian et al.
SEMINARS IN CANCER BIOLOGY (2021)
Hydrogen sulfide and vascular regulation - An update
Boyang Lv et al.
JOURNAL OF ADVANCED RESEARCH (2021)
In Defense of the Nucleus: NUDT1 and Oxidative DNA Damage in Pulmonary Arterial Hypertension
Stuti Agarwal et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases
Zicheng Deng et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)
Inhaled bosentan microparticles for the treatment of monocrotaline-induced pulmonary arterial hypertension in rats
Hyo-Jung Lee et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Synergistic Enzyme Mixtures to Realize Near-Complete Depolymerization in Biodegradable Polymer/Additive Blends
Christopher DelRe et al.
ADVANCED MATERIALS (2021)
Fundamental aspects of the non-covalent modification of cellulose via polymer adsorption
Vishnu Arumughan et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2021)
Nanomedicine for the treatment of diabetes-associated cardiovascular diseases and fibrosis
Xiao-Min Luo et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Risk Stratification in Pulmonary Arterial Hypertension: Do Not Forget the Patient Perspective
Marc Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
ERS statement on chronic thromboembolic pulmonary hypertension
Marion Delcroix et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Three-Dimensional Visualization of Hypoxia-Induced Pulmonary Vascular Remodeling in Mice
Takayuki Fujiwara et al.
CIRCULATION (2021)
Microfluidic fabrication of inhalable large porous microspheres loaded with H2S-releasing aspirin derivative for pulmonary arterial hypertension therapy
Hui Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
Aaron Waxman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP)
Barbara Stollfuss et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2021)
Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension
Kelly M. Chin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Endothelial cells in the pathogenesis of pulmonary arterial hypertension
Colin E. Evans et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery
Hongfei Xu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy
Ying Zhu et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Dose-Independent Transfection of Hydrophobized Polyplexes
Zhen Zhang et al.
ADVANCED MATERIALS (2021)
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances
Bradley A. Maron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
A statistical framework for determination of minimal plasmid copy number required for transgene expression in mammalian cells
Liangli Wang et al.
BIOELECTROCHEMISTRY (2021)
Nanozymes for regulation of reactive oxygen species and disease therapy
Yujie Dai et al.
CHINESE CHEMICAL LETTERS (2021)
ALDH1A3 Coordinates Metabolism With Gene Regulation in Pulmonary Arterial Hypertension
Dan Li et al.
CIRCULATION (2021)
MoS2-based nanocomposites for cancer diagnosis and therapy
Jianling Wang et al.
BIOACTIVE MATERIALS (2021)
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
Marc Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
Marius M. Hoeper et al.
LANCET RESPIRATORY MEDICINE (2021)
Emerging strategies in developing multifunctional nanomaterials for cancer nanotheranostics
Melgious Jin Yan Ang et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Liposome composition in drug delivery design, synthesis, characterization, and clinical application
Danielle E. Large et al.
ADVANCED DRUG DELIVERY REVIEWS (2021)
Electroactive Biomaterials and Systems for Cell Fate Determination and Tissue Regeneration: Design and Applications
Zhirong Liu et al.
ADVANCED MATERIALS (2021)
Advances in amphiphilic polylactide/vinyl polymer based nano-assemblies for drug delivery
Didier Gigmes et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2021)
Upfront Combination Therapy for Pulmonary Arterial Hypertension: Time to Be More Ambitious than AMBITION
Thomas M. Cascino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension
Athenais Boucly et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)
Metabolic Syndrome Mediates ROS-miR-193b-NFYA-Dependent Downregulation of Soluble Guanylate Cyclase and Contributes to Exercise-Induced Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction
Taijyu Satoh et al.
CIRCULATION (2021)
Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia
Fei Sun et al.
CIRCULATION (2021)
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su et al.
DRUG RESISTANCE UPDATES (2021)
Nanomaterials for cancer therapy: current progress and perspectives
Zhe Cheng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)
Obstacles and opportunities in a forward vision for cancer nanomedicine
Irene de Lazaro et al.
NATURE MATERIALS (2021)
The current landscape of nucleic acid therapeutics
Jayesh A. Kulkarni et al.
NATURE NANOTECHNOLOGY (2021)
Intravenous Delivery of Lung-Targeted Nanofibers for Pulmonary Hypertension in Mice
Kathleen Marulanda et al.
ADVANCED HEALTHCARE MATERIALS (2021)
Recent Progress in Nanoscale Covalent Organic Frameworks for Cancer Diagnosis and Therapy
Shuncheng Yao et al.
NANO-MICRO LETTERS (2021)
Inhaled treprostinil and forced vital capacity in patients with interstitial lung disease and associated pulmonary hypertension: a post-hoc analysis of the INCREASE study
Steven D. Nathan et al.
LANCET RESPIRATORY MEDICINE (2021)
Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension
Wenrui Ma et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Hydrogen Sulfide Metabolism and Pulmonary Hypertension
Lukas Roubenne et al.
CELLS (2021)
Inorganic nanomaterials with rapid clearance for biomedical applications
Xianwen Wang et al.
CHEMICAL SOCIETY REVIEWS (2021)
Risk Reduction and Right Heart Reverse Remodeling by Upfront Triple Combination Therapy in Pulmonary Arterial Hypertension
Michele D'Alto et al.
CHEST (2020)
Established and emerging therapeutic uses of PDE type 5 inhibitors in cardiovascular disease
Nikolaos Tzoumas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Feedback-controlled photolytic gas phase nitric oxide delivery from S-nitrosothiol-doped silicone rubber films
Gergely Lautner et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Potential application of liposomal nanodevices for non-cancer diseases: an update on design, characterization and biopharmaceutical evaluation
Fereshteh Bayat et al.
ADVANCES IN COLLOID AND INTERFACE SCIENCE (2020)
High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury
Erik Stites et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Transition from intravenous epoprostenol to selexipag in pulmonary arterial hypertension: a word of caution
Kenichi Yanaka et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Treatment of pulmonary hypertension with riociguat: a review of current evidence and future perspectives
Afroditi K. Boutou et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial
Ioana R. Preston et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
The challenge of an expanded therapeutic window in pulmonary hypertension
Simon Stewart et al.
NATURE REVIEWS CARDIOLOGY (2020)
Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension
Hebah A. Sindi et al.
NATURE COMMUNICATIONS (2020)
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis
Masataka Kuwana et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Nanomedicine to target multidrug resistant tumors
Elise Lepeltier et al.
DRUG RESISTANCE UPDATES (2020)
IL-6 in pulmonary hypertension: why novel is not always best
Mark Toshner et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
Olivier Sitbon et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
Susana Carregal-Romero et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Safety Considerations of Cancer Nanomedicine-A Key Step toward Translation
Xiangsheng Liu et al.
SMALL (2020)
Challenges in nanomedicine clinical translation
Josbert M. Metselaar et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2020)
Liposomes: Advancements and innovation in the manufacturing process
Sanket Shah et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2
Ye Fan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Periostin A Potential Therapeutic Target For Pulmonary Hypertension?
Xiaowei Nie et al.
CIRCULATION RESEARCH (2020)
Recent trends in nanopore polymer functionalization
Robert Brilmayer et al.
CURRENT OPINION IN BIOTECHNOLOGY (2020)
Molecular Design of Layer-by-Layer Functionalized Liposomes for Oral Drug Delivery
Wing-Fu Lai et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
Duhyeong Hwang et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Tumor-Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity
Ju Hee Ryu et al.
ADVANCED MATERIALS (2020)
Rieske iron-sulfur protein induces FKBP12.6/RyR2 complex remodeling and subsequent pulmonary hypertension through NF-κB/cyclin D1 pathway
Lin Mei et al.
NATURE COMMUNICATIONS (2020)
Delivering the power of nanomedicine to patients today
Matthieu Germain et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Pulmonary Hypertension: A Brief Guide for Clinicians
Stacy A. Mandras et al.
MAYO CLINIC PROCEEDINGS (2020)
The Effects of Single Nucleotide Polymorphisms in Cancer RNAi Therapies
Magdalena Gebert et al.
CANCERS (2020)
Amorphous nano-selenium quantum dots prevent pulmonary arterial hypertension through recoupling endothelial nitric oxide synthase
Mo-Li Zhu et al.
Aging-US (2020)
DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment
Zerong Li et al.
DRUG DELIVERY (2020)
BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension
Qiujun Yu et al.
CIRCULATION (2019)
Knockout of dihydrofolate reductase in mice induces hypertension and abdominal aortic aneurysm via mitochondrial dysfunction
Qiang Li et al.
REDOX BIOLOGY (2019)
The S52F FOXF1 Mutation Inhibits STAT3 Signaling and Causes Alveolar Capillary Dysplasia
Arun Pradhan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Comparison of different chemically modified inhibitors of miR-199b in vivo
Burcu Duygu et al.
BIOCHEMICAL PHARMACOLOGY (2019)
Preparation and characterization of bosentan monohydrate/ε-polycaprolactone nanoparticles obtained by electrospraying
Virna M. Gimenez et al.
BIOTECHNOLOGY PROGRESS (2019)
CLIC4/Arf6 Pathway A New Lead in BMPRII Inhibition in Pulmonary Hypertension
Vahitha B. Abdul-Salam et al.
CIRCULATION RESEARCH (2019)
Circ_Lrp6, a Circular RNA Enriched in Vascular Smooth Muscle Cells, Acts as a Sponge Regulating miRNA-145 Function
Ignacio Fernando Hall et al.
CIRCULATION RESEARCH (2019)
Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling
Bingbing Li et al.
HYPERTENSION (2019)
Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension
R. James White et al.
RESPIRATORY RESEARCH (2019)
CAR, a Homing Peptide, Prolongs Pulmonary Preferential Vasodilation by Increasing Pulmonary Retention and Reducing Systemic Absorption of Liposomal Fasudil
Ali Keshavarz et al.
MOLECULAR PHARMACEUTICS (2019)
PLGA Spherical Nucleic Acids
Shengshuang Zhu et al.
ADVANCED MATERIALS (2018)
How Many FOXs Are There on The Road to Pulmonary Hypertension?
Kurt R. Stenmark et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Site-selective protein modification with polymers for advanced biomedical applications
Xinyu Liu et al.
BIOMATERIALS (2018)
Block Copolymer Micelles in Nanomedicine Applications
Horacio Cabral et al.
CHEMICAL REVIEWS (2018)
Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension
Pierre-Simon Bellaye et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Repurposing rosiglitazone, a PPAR-γ agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH
Jahidur Rashid et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Cerivastatin Nanoliposome as a Potential Disease Modifying Approach for the Treatment of Pulmonary Arterial Hypertension
Young Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2018)
ROS signaling and ER stress in cardiovascular disease
Cristhiaan D. Ochoa et al.
MOLECULAR ASPECTS OF MEDICINE (2018)
Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery
Jahidur Rashid et al.
MOLECULAR PHARMACEUTICS (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Nanoparticle-Mediated Targeting of Pitavastatin to Small Pulmonary Arteries and Leukocytes by Intravenous Administration Attenuates the Progression of Monocrotaline-Induced Established Pulmonary Arterial Hypertension in Rats
Kenzo Ichimura et al.
INTERNATIONAL HEART JOURNAL (2018)
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Reiner Frey et al.
CLINICAL PHARMACOKINETICS (2018)
Light-Responsive Biodegradable Nanorattles for Cancer Theranostics
Chunxiao Li et al.
ADVANCED MATERIALS (2018)
Lipid-based carriers for controlled delivery of nitric oxide
Mahmoud A. Elnaggar et al.
EXPERT OPINION ON DRUG DELIVERY (2017)
Rapamycin nanoparticles localize in diseased lung vasculature and prevent pulmonary arterial hypertension
Victor Segura-Ibarra et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization
Rui Ni et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Cocktail of Superoxide Dismutase and Fasudil Encapsulated in Targeted Liposomes Slows PAH Progression at a Reduced Dosing Frequency
Nilesh Gupta et al.
MOLECULAR PHARMACEUTICS (2017)
Epidemiology and treatment of pulmonary arterial hypertension
Edmund M. T. Lau et al.
NATURE REVIEWS CARDIOLOGY (2017)
ATG101 Single-Stranded Antisense RNA-Loaded Triangular DNA Nanoparticles Control Human Pulmonary Endothelial Growth via Regulation of Cell Macroautophagy
Juan Du et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Development of dry powder inhaler containing tadalafil-loaded PLGA nanoparticles
Jaleh Varshosaz et al.
RESEARCH IN PHARMACEUTICAL SCIENCES (2017)
Respirable controlled release polymeric colloid (RCRPC) of bosentan for the management of pulmonary hypertension: in vitro aerosolization, histological examination and in vivo pulmonary absorption
Lydia A. Hanna et al.
DRUG DELIVERY (2017)
Virus-inspired nucleic acid delivery system: Linking virus and viral mimicry
Rong Ni et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH
Kamrun Nahar et al.
PHARMACEUTICAL RESEARCH (2016)
A global view of pulmonary hypertension
Marius M. Hoeper et al.
LANCET RESPIRATORY MEDICINE (2016)
Regulation of vascular smooth muscle cell autophagy by DNA nanotube-conjugated mTOR siRNA
Zaichun You et al.
BIOMATERIALS (2015)
Delivery of Imatinib-Incorporated Nanoparticles into Lungs Suppresses the Development of Monocrotaline-Induced Pulmonary Arterial Hypertension
Satoshi Akagi et al.
International Heart Journal (2015)
Fasudil and SOD packaged in peptide-studded-liposomes: Properties, pharmacokinetics and ex-vivo targeting to isolated perfused rat lungs
Nilesh Gupta et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Lipid nanoparticle delivery of a microRNA-145 inhibitor improves experimental pulmonary hypertension
Jared M. McLendon et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Encapsulation of beraprost sodium in nanoparticles: Analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertension
Tomoaki Ishihara et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Novel and Emerging Therapies for Pulmonary Hypertension
Soni Savai Pullamsetti et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension
Madhukar B. Kolli et al.
BIOMATERIALS (2014)
Liposomal nanoparticles encapsulating iloprost exhibit enhanced vasodilation in pulmonary arteries
Pritesh P. Jain et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature
Kamrun Nahar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Peptide-Micelle Hybrids Containing Fasudil for Targeted Delivery to the Pulmonary Arteries and Arterioles to Treat Pulmonary Arterial Hypertension
Nilesh Gupta et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Peptide-Coated Liposomal Fasudil Enhances Site Specific Vasodilation in Pulmonary Arterial Hypertension
Kamrun Nahar et al.
MOLECULAR PHARMACEUTICS (2014)
Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension
Rajkumar Savai et al.
NATURE MEDICINE (2014)
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
James E. Dahlman et al.
NATURE NANOTECHNOLOGY (2014)
Non-viral vectors for gene-based therapy
Hao Yin et al.
NATURE REVIEWS GENETICS (2014)
Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension
Vivek Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface
Anna Salvati et al.
NATURE NANOTECHNOLOGY (2013)
The Potential Efficacy of R8-Modified Paclitaxel-Loaded Liposomes on Pulmonary Arterial Hypertension
Yujia Yin et al.
PHARMACEUTICAL RESEARCH (2013)
Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice
Huili Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
MATERIALS CHEMISTRY Liposomes derived from molecular vases
Cyrus R. Safinya et al.
NATURE (2012)
Peptide-Directed Highly Selective Targeting of Pulmonary Arterial Hypertension
Takeo Urakami et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc
Zhe Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Nanoparticle-Mediated Delivery of Nuclear Factor κB Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension
Satoshi Kimura et al.
HYPERTENSION (2009)